From the Leni and Peter W. May Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, NY.
J Am Acad Orthop Surg Glob Res Rev. 2024 Sep 13;8(9). doi: 10.5435/JAAOSGlobal-D-24-00005. eCollection 2024 Sep 1.
For patients unsuitable for prosthesis reimplantation or temporary spacer placement, Girdlestone resection arthroplasty (GRA) is a suitable option to eliminate infection. Using a large-scale database, this study aims to determine factors associated with reimplantation.
This study included patients who underwent GRA and subsequent total hip arthroplasty (2012 to 2015 Medicare Limited Data Set with ≥5-year follow-up). A mixed-effects model measured associations between patient characteristics and reimplantation. Odds ratios (OR) with 95% confidence intervals (CI) were reported.
Among 2,772 GRA cases, 2,025 (73.1%) were reimplanted (median time to reimplantation 3.0 months). In multivariable analysis, patient factors associated with reduced odds of reimplantation were increased age (OR 0.96; CI, 0.94 to 0.97; P < 0.0001), Black race (OR, 0.58; CI, 0.37 to 0.90; P = 0.0149), obesity (OR, 0.74; CI, 0.58 to 0.94; P = 0.0150), and increased Deyo-Charlson comorbidities (1 comorbidity: OR, 0.78; CI, 0.61 to 0.99; P = 0.0453; two comorbidities: OR, 0.53; CI, 0.39 to 0.71; P < 0.0001; ≥3 comorbidities: OR, 0.69; CI, 0.49 to 0.95; P = 0.0244). Male (versus female) patients, however, had increased odds of reimplantation (OR, 1.64; CI, 1.32 to 2.02; P < 0.0001).
Age, race, and comorbidities influence the likelihood of reimplantation after GRA. Owing to variability in patients who undergo additional surgery, additional studies should be conducted to determine the rationale of patient selection.
对于不适合假体再植入或临时间隔物放置的患者,Girdlestone 切除术(GRA)是消除感染的一种合适选择。本研究使用大规模数据库,旨在确定与再植入相关的因素。
本研究纳入了接受 GRA 并随后接受全髋关节置换术(2012 年至 2015 年 Medicare 有限数据集,随访时间≥5 年)的患者。混合效应模型测量了患者特征与再植入之间的关联。报告了比值比(OR)及其 95%置信区间(CI)。
在 2772 例 GRA 病例中,2025 例(73.1%)进行了再植入(再植入的中位时间为 3.0 个月)。多变量分析显示,与再植入可能性降低相关的患者因素包括年龄增加(OR 0.96;CI,0.94 至 0.97;P<0.0001)、黑种人(OR,0.58;CI,0.37 至 0.90;P=0.0149)、肥胖(OR,0.74;CI,0.58 至 0.94;P=0.0150)和增加的 Deyo-Charlson 合并症(1 种合并症:OR,0.78;CI,0.61 至 0.99;P=0.0453;2 种合并症:OR,0.53;CI,0.39 至 0.71;P<0.0001;≥3 种合并症:OR,0.69;CI,0.49 至 0.95;P=0.0244)。然而,男性(与女性相比)患者再植入的可能性增加(OR,1.64;CI,1.32 至 2.02;P<0.0001)。
年龄、种族和合并症影响 GRA 后的再植入可能性。由于接受额外手术的患者存在差异,应进行更多研究以确定患者选择的原理。